UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status No longer recruiting
Unique ID issued by UMIN UMIN000023991
Receipt No. R000027615
Scientific Title The effectiveness of the gentle mechanical skin stimulation for overactive bladder; a randomized, placebo-controlled, double-blind trial.
Date of disclosure of the study information 2016/09/12
Last modified on 2017/09/11

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title The effectiveness of the gentle mechanical skin stimulation for overactive bladder; a randomized, placebo-controlled, double-blind trial.
Acronym The effectiveness of the gentle mechanical skin stimulation for overactive bladder.
Scientific Title The effectiveness of the gentle mechanical skin stimulation for overactive bladder; a randomized, placebo-controlled, double-blind trial.
Scientific Title:Acronym The effectiveness of the gentle mechanical skin stimulation for overactive bladder.
Region
Japan

Condition
Condition Overactive bladder
Classification by specialty
Geriatrics Urology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 We construct a new self-care model for overactive bladder using somatosensory stimulation, and clarify its effectiveness. In our previous study, the perineal skin stimulation with a roller that was performed by participants themselves at bedtime for three days reduced the nocturia frequency caused by overactive bladder. In this study, we examine the effects of long-term use of this self-administered method for future clinical application.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2 Pragmatic
Developmental phase Phase II,III

Assessment
Primary outcomes Urinary frequency per day before, during and after the intervention period.
The urinary frequency is calculated from time of urination recorded in urinary diary.
Key secondary outcomes We assess the following outcomes during each period; before, during and after the intervention.
-Subjective symptoms of overactive bladder. (with Overactive Bladder Symptoms Score: OABSS)
-The influence of overactive bladder symptoms on daily life. (with King's Health Questionnaire: KHQ)
-The influence on sleep quality.
-Costs associated with care for frequent urination.
-Impression of the self-administered intervention (record during intervention periods only).
-volume of fluid intake (recorded on urinary diary)

Base
Study type Interventional

Study design
Basic design Cross-over
Randomization Randomized
Randomization unit Individual
Blinding Double blind -all involved are blinded
Control Placebo
Stratification YES
Dynamic allocation YES
Institution consideration Institution is not considered as adjustment factor.
Blocking NO
Concealment No need to know

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Device,equipment
Interventions/Control_1 In intervention 1, the first three days-one week is the pre-intervention period that does not include intervention. The next 4 weeks are the intervention period. In intervention periods, participants stimulate perineal skin with an active roller (somaplane) by themselves. The subsequent 2 weeks are the follow-up period and, we observe conditions after stimulation.
Participants apply skin stimulation by themselves with an active roller following each urination as possible. This skin stimulation is applied slowly and gently on the perineal area for 1 minute using roller.
(If the study design is changed into a crossover design, the interventions 1 and 2 (see below) are performed for 2 weeks each. Washout period is 2 weeks between each intervention period. In intervention 1, participants use an active roller first, and use placebo roller after washout.)
Interventions/Control_2 In intervention 2, first three days-one week is the pre-intervention period that does not include intervention. The following 4 weeks are the intervention period. In the intervention period, participants stimulate the perineal skin with a placebo roller by themselves. The subsequent 2 weeks are the follow-up periods and we observe conditions after stimulation.
Participants apply skin stimulation by themselves with a placebo roller after each urination as possible. This skin stimulation is applied slowly and gently on the perineal area for 1 minute.
(If the study design is changed into a crossover design, the interventions 1 and 2 are performed for 2 weeks each. Washout period is 2 weeks between each intervention period. In intervention 2, participants use a placebo roller first, and use an active roller after washout.)
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
60 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria -Having nocturnal urination one or more times.
-Having diagnosed with overactive bladder.
-Not taking anticholinergic drugs prescribed by a doctor for two weeks before trial registration.
-Being able to visit our hospital during study periods.
-Having agreement with their participation in writing.
Key exclusion criteria -Having residual urine of more than 100ml.
-Having diagnosed with prostatic hyperplasia.
-Having the underlying disease such as bladder cancer, urinary calculi, inflammatory lower urinary tract.
-Having dementia suspects.
-Being considered in appropriate by a clinician.
Target sample size 16

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Kasuya Yutaka
Organization Tokyo Metropolitan Geriatric Hospital
Division name Urology
Zip code
Address 35-2 Sakaecho, Itabashi-ku, Tokyo
TEL 03-3964-1141
Email kasuya_yutaka@tmghig.jp

Public contact
Name of contact person
1st name
Middle name
Last name Hotta Harumi
Organization Tokyo Metropolitan Institute of Gerontology
Division name Autonomic Neuroscience
Zip code
Address 35-2 Sakaecho, Itabashi-ku, Tokyo
TEL 03-3964-3241(4343)
Homepage URL
Email hhotta@tmig.or.jp

Sponsor
Institute Tokyo Metropolitan Institute of Gerontology
Institute
Department

Funding Source
Organization Tokyo Metropolitan Institute of Gerontology
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization Japan

Other related organizations
Co-sponsor Teikyo Heisei University
Name of secondary funder(s) None

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 東京都健康長寿医療センター(東京都)/Tokyo Metropolitan Institute of Gerontology (Tokyo)

Other administrative information
Date of disclosure of the study information
2016 Year 09 Month 12 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status No longer recruiting
Date of protocol fixation
2016 Year 07 Month 08 Day
Date of IRB
Anticipated trial start date
2016 Year 09 Month 09 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2016 Year 09 Month 09 Day
Last modified on
2017 Year 09 Month 11 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027615

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.